Qualigen Therapeutics has completed a $41 million PIPE financing round led by Faraday Future Intelligent E, marking a strategic shift towards Web3 and cryptocurrency. Jia Yueting, founder and global co-CEO of Faraday Future, personally invested $4 million, securing a 7% stake, while Faraday Future invested $30 million for a 55% stake. The funds will support Qualigen's expansion into crypto-related businesses, including the development of the C10 value anchor system and DeAI smart agents. The company plans to rebrand as CXC10, focusing on three growth engines and six core products. Additionally, FF CFO Koti Meka will assume the role of Qualigen's CFO.